Full Text View
Tabular View
No Study Results Posted
Related Studies
Prediction of Childhood Epilepsy Outcome in Bangladesh
This study has been completed.
Study NCT00381537   Information provided by Institute of Child Health
First Received: September 27, 2006   Last Updated: December 22, 2006   History of Changes

September 27, 2006
December 22, 2006
 
 
 
 
Complete list of historical versions of study NCT00381537 on ClinicalTrials.gov Archive Site
 
 
 
Prediction of Childhood Epilepsy Outcome in Bangladesh
 

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

 
 
Interventional
Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Epilepsy
  • Drug: phenobarbitone
  • Drug: carbamazepine
 
Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, Neville B. Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ. 2007 Jun 9;334(7605):1207. Epub 2006 Dec 4.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
92
 
 

Inclusion Criteria:

  • Active epilepsy
  • Aged 2-15 years

Exclusion Criteria:

  • Excluded absence
  • Myoclonic and malignant epilepsy syndromes
  • Major motor and cognitive impairments
  • Those currently receiving antiepilepsy drugs.
Both
2 Years to 16 Years
No
Contact information is only displayed when the study is recruiting subjects
Bangladesh,   United Kingdom
 
NCT00381537
 
99NR58
Institute of Child Health
 
Principal Investigator: Brian Neville, Professor Institute of Child Health
Principal Investigator: Selina Banu, Dr Children’s Hospital Dhaka (Shishu) Bangladesh.
Institute of Child Health
December 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP